Just saw this exchange between Musk and Cuban on X that's worth paying attention to. Musk basically asked a straightforward question — why can't Americans get real value for what they're spending on healthcare? — and Cuban didn't hold back with his response.

What's interesting is that Cuban didn't blame the government or some abstract "system." Instead, he went after the actual players making money off the current setup: the pharmacy benefit managers and the contracts companies sign with them. And honestly, once you see how these deals work, it's hard to unsee.

He broke down seven specific ways the system is rigged against both employers and patients. The one that stood out to me is that companies literally don't own their own claims data. They're paying the bills but can't even see where the money's going. That's insane. Then there's the part about PBMs deciding which drugs employees can access instead of the companies actually footing the bill. They'll push expensive medications over cheaper alternatives because that's where the rebates are.

Cuban called out "specialty drugs" as basically a pricing scam — drugs that aren't actually special, just marked up to be expensive. And the way rebates are structured? The sickest employees end up paying the most. Independent pharmacies get squeezed out because PBMs reimburse them below cost. CEOs can't negotiate directly with manufacturers, and half these contracts have NDAs that literally prevent them from talking about the deal publicly.

But here's where it gets interesting — Cuban isn't just complaining. He's actually building something different with Cost Plus Drugs, cutting out the middlemen entirely and selling direct to consumers. No hidden fees, full transparency on pricing.

The whole thing feels like a potential inflection point. If this model actually scales, it could force some real change in how the industry operates. Definitely worth watching how this plays out over the next year.